Dermata Therapeutics, Inc. — Director's Dealing 2021

Aug 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Dermata Therapeutics, Inc. (DRMA)
CIK: 0001853816
Period of Report: 2021-08-17

Reporting Person: Proehl Investment Ventures LLC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-17	Common Stock	C	361147	—	Acquired	1278464	Direct
2021-08-17	Common Stock	C	111951	—	Acquired	1390415	Direct
2021-08-17	Common Stock	C	181585	—	Acquired	1572000	Direct
2021-08-17	Common Stock	C	1247904	—	Acquired	2819904	Direct
2021-08-17	Common Stock	C	85640	—	Acquired	2905544	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-17	Series 1d Preferred Stock	$	C	2436657	Disposed		Common Stock (361147)	Direct
2021-08-17	Series 1a Preferred Stock	$	C	2295000	Disposed		Common Stock (111951)	Direct
2021-08-17	Series 1b Preferred Stock	$	C	3722500	Disposed		Common Stock (181585)	Direct
2021-08-17	Series 1c Preferred Stock	$	C	25582050	Disposed		Common Stock (1247904)	Direct
2021-08-17	Series 1 Preferred Stock	$	C	1755622	Disposed		Common Stock (85640)	Direct
2021-08-17	Series 1a Warrants	$	C	573750	Disposed	2026-03-14	Common Stock (27987)	Direct
2021-08-17	Warrant to Purchase Common Stock	$20.50	C	27987	Acquired	2026-03-14	Common Stock (27987)	Direct

Footnotes

F1: The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date.

F2: The Series 1a Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1a Preferred Stock was convertible at any time and had no expiration date.

F3: The Series 1b Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1b Preferred Stock was convertible at any time and had no expiration date.

F4: The Series 1c Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1c Preferred Stock was convertible at any time and had no expiration date.

F5: The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1 Preferred Stock was convertible at any time and had no expiration date.

F6: The Series 1a Preferred Warrants converted into warrants to purchase Common Stock in connection with the IPO.